Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB25FBRYP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $119,882
Award facts
- Contract value 100% obligated
- $119,882.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $119,882.45 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of SKYRIZI 150 MG/ML in pen-milliliter format. This competitive award, executed under firm fixed pricing with no set-aside designation, is scheduled for completion by September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. SKYRIZI is a biologic medication used in the treatment of inflammatory skin conditions, and this delivery order represents a continuation of the company's ongoing role as a critical supplier to federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a broad portfolio of medications and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract awards demonstrate its established capability to meet competitive federal procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FBRYP?
SPE2DB25FBRYP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FBRYP worth?
The government has obligated $119,882 on SPE2DB25FBRYP.
Is contract SPE2DB25FBRYP an order under another contract?
Yes. SPE2DB25FBRYP is a delivery order under SPE2DB24D2011, an indefinite delivery contract.
Was contract SPE2DB25FBRYP competed?
The extent of competition for SPE2DB25FBRYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award